NextPlat (NXPL) Other Operating Expenses (2010 - 2026)
NextPlat's (NXPL) quarterly Other Operating Expenses came in at $2.4 million in Q2 2026, up 1557.67% year-over-year from $143333.8 in Q2 2025, and down 5.3% quarter-over-quarter from $2.5 million in Q1 2026.
Analysis
NextPlat (NXPL) Other Operating Expenses (2010 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Other Operating Expenses for 16 consecutive years, with $2.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Operating Expenses rose 1557.67% year-over-year to $2.4 million in Q2 2026; TTM through Jun 2026 was $4.6 million, a 63.09% increase from a year earlier, with the FY2025 full-year figure at -$250000.0, down 365.96% from the prior year.
- Other Operating Expenses was $2.4 million for Q2 2026 at NextPlat, down from $2.5 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $5.3 million in Q1 2024 and troughed at -$250000.0 in Q3 2025.
- A 5-year average of $1.6 million and a median of $1.1 million in 2022 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses tumbled 355.1% in 2025 and soared 1557.67% in 2026, its largest moves.
- Over 5 years, Other Operating Expenses stood at $1.5 million in 2022, then surged by 127.52% to $3.3 million in 2023, then slumped by 100.12% to -$4000.0 in 2024, then tumbled by 6150.0% to -$250000.0 in 2025, then jumped by 1050.4% to $2.4 million in 2026.
- The last three Other Operating Expenses figures came in at $2.4 million (Q2 2026), $2.5 million (Q1 2026), and -$250000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.38 Mn |
| Mar 31, 2026 | 2.51 Mn |
| Sep 30, 2025 | -250,000.00 |
| Jun 30, 2025 | -163,000.00 |
| Mar 31, 2025 | 2.91 Mn |
| Dec 31, 2024 | -4,000.00 |
| Sep 30, 2024 | 98,000.00 |
| Mar 31, 2024 | 5.33 Mn |
| Mar 31, 2023 | 3.33 Mn |
| Dec 31, 2022 | 1.46 Mn |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 939,783.00 |
| Mar 31, 2022 | 1.06 Mn |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 889,222.00 |
| Jun 30, 2021 | 808,820.00 |
| Mar 31, 2021 | 560,556.00 |
| Dec 31, 2020 | 1.19 Mn |
| Sep 30, 2020 | 690,022.00 |
| Jun 30, 2020 | 299,971.00 |